Nano-enabled delivery of diverse payloads across complex biological barriers

Journal of Controlled Release : Official Journal of the Controlled Release Society
Kathleen A RossBalaji Narasimhan

Abstract

Complex biological barriers are major obstacles for preventing and treating disease. Nanocarriers are designed to overcome such obstacles by enhancing drug delivery through physiochemical barriers and improving therapeutic indices. This review critically examines both biological barriers and nanocarrier payloads for a variety of drug delivery applications. A spectrum of nanocarriers is discussed that have been successfully developed for improving tissue penetration for preventing or treating a range of infectious, inflammatory, and degenerative diseases.

References

Oct 1, 1973·Journal of Gerontology·M Rockstein, J Chesky
Apr 1, 1983·Biomaterials·H B RosenR Langer
Jun 19, 1995·Brain Research·S SkarlatosW M Pardridge
Dec 1, 1994·Journal of Biomedical Materials Research·L ShiehR Langer
Jan 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·J A Tamada, R Langer
Sep 28, 1999·Peptides·W Pan, A J Kastin
Oct 4, 2000·Journal of Pharmaceutical Sciences·I Tamai, A Tsuji
Feb 22, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·H Q MaoK W Leong
Dec 6, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·K OgawaraT Kimura
Jul 11, 2002·Proceedings of the National Academy of Sciences of the United States of America·Patrik AnderssonLorenz Poellinger
Aug 8, 2002·Journal of Drug Targeting·Jörg KreuterRenad Alyautdin
Aug 23, 2002·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Andrea GessnerRainer Müller
Aug 27, 2002·Biomaterials·Friederike von BurkersrodaAchim Göpferich
Mar 8, 2003·Drug Discovery Today·Vladimir P Torchilin, Anatoly N Lukyanov
Oct 17, 2003·European Cells & Materials·P A Gunatillake, R Adhikari
Apr 28, 2004·Advanced Drug Delivery Reviews·Anatoly N Lukyanov, Vladimir P Torchilin
Jun 3, 2004·Journal of Biomedical Materials Research. Part a·Fenghua MengJan Feijen
Jun 23, 2004·Biomaterials·Blaine A PfeiferRobert Langer
Oct 20, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Amy S DetermanBalaji Narasimhan
Oct 29, 2004·Nature Reviews. Cancer·Carl-Henrik HeldinArne Ostman
Nov 5, 2004·Cellular and Molecular Life Sciences : CMLS·V P Torchilin
Jan 29, 2005·Drug Discovery Today·Elizabeth R Gillies, Jean M J Fréchet
Apr 29, 2005·Journal of Pharmaceutical Sciences·Candace L Graff, Gary M Pollack
Jul 30, 2005·Nature Reviews. Drug Discovery·Daniel W PackPatrick S Stayton
Nov 18, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Geneviève GaucherJean-Christophe Leroux
Nov 22, 2005·Expert Opinion on Drug Delivery·Pieter J GaillardAlbertus G de Boer
Feb 17, 2006·Acta neurochirurgica·M WestphalUNKNOWN Executive Committee of the Gliadel Study Group
Mar 24, 2006·The Journal of Pharmacology and Experimental Therapeutics·K MichaelisK Langer
Mar 29, 2006·Proceedings of the National Academy of Sciences of the United States of America·Robert G Thorne, Charles Nicholson
May 13, 2006·Journal of Biomaterials Science. Polymer Edition·Carlos E Astete, Cristina M Sabliov
May 23, 2006·Trends in Parasitology·Janet HemingwayBrian L Sharp

❮ Previous
Next ❯

Citations

Feb 20, 2016·Therapeutic Delivery·C GuiotR Cavalli
Jun 9, 2016·Advanced Drug Delivery Reviews·Miles A Miller, Ralph Weissleder
Jan 13, 2018·Human Gene Therapy·Li LiuYuquan Wei
Oct 29, 2018·Journal of Biomedical Materials Research. Part a·Timothy M BrenzaGeorgette D Kanmogne
Sep 9, 2020·PLoS Neglected Tropical Diseases·Edmund J NorrisLyric C Bartholomay
Aug 8, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Xiaoli WuJin Chang
Feb 23, 2020·Pharmaceutics·Florina-Daniela CojocaruCosmin-Teodor Mihai
Sep 22, 2020·Biomaterials Science·Chengyuan QianXiaohui Wang
Dec 4, 2020·Emerging Topics in Life Sciences·Joanna Shepherd
Dec 16, 2020·Emerging Topics in Life Sciences·Parasuraman PadmanabhanBalázs Gulyás
Dec 21, 2018·Journal of Controlled Release : Official Journal of the Controlled Release Society·Paul LuethBryan H Bellaire
Oct 25, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Timothy M BrenzaBalaji Narasimhan
Mar 11, 2021·Drug Metabolism Reviews·Shreya R SavlaYogesh A Kulkarni
May 13, 2021·ACS Biomaterials Science & Engineering·Elham BidramPooyan Makvandi
Jul 28, 2021·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Benjamin W SchlichtmannBalaji Narasimhan
Jan 1, 2019·Industrial & Engineering Chemistry Research·Marissa E WechslerNicholas A Peppas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved